Zhihua Liu

56PUBLICATIONS
157CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisInnate immunityCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Sep 21, 2026
CX3CR1⁺ CD8⁺ cytotoxic T cells drive tumor killing in esophageal squamous cell carcinoma during neoadjuvant therapy.

|Jun 19, 2026
CTSC-RAB38 Potentiates Responsiveness to PD-1 Blockade in Esophageal Squamous Cell Carcinoma.

|Feb 24, 2026
Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer.

Yabing Nan, Kunyu Wang, Menghan Hu

|Feb 19, 2026
The consensus molecular subtypes of esophageal squamous cell carcinoma.

Heyang Cui, Zhongxu Zhu, Enwei Xu

|Dec 08, 2025
IgG-Bridging-Seeded Synergistic Aggregation of SARS-CoV-2 Spikes Underlies Potent Neutralization by a Low-Affinity Antibody.

Niannian Lv, Peng Chen, Xiaobin Dai

|Nov 03, 2025
Targeting the ATM-TGS1-BRCA1 Axis Overcomes Genotoxic Therapy Resistance in Pancreatic Adenocarcinoma.

Changying Li, Xuran Zhao, Xinyan Li

Pageof 10

Frequent Collaborators

9 joint publications

Hongyan Chen

7 joint publications

Qingyu Luo

6 joint publications

Xiaowei Wu

6 joint publications

Jianzhong Su